Copyright
©The Author(s) 2016.
World J Stem Cells. Apr 26, 2016; 8(4): 158-169
Published online Apr 26, 2016. doi: 10.4252/wjsc.v8.i4.158
Published online Apr 26, 2016. doi: 10.4252/wjsc.v8.i4.158
Disease categories | Diseases or status | Features relevant to the diseases | Ref. |
Infectious diseases | Pneumopathy | Decrease in frequency and absolute number of MAIT cells in peripheral blood | [16] |
Tuberculosis (Mycobacterium tuberculosis) | Decrease in frequency and absolute number of MAIT cells in peripheral blood Enriched in the lung | [16,37,92] | |
HIV/AIDS (opportunistic infection) | Decrease in frequency of MAIT cells in peripheral blood, guts, and lymph nodes Failure of recovery of blood MAIT cells with successful cART Long-term cART restore colonic but not blood MAIT cell levels MAIT cells are depleted but retain functionality | [38-43,93,94] | |
Sepsis (severe bacterial infection) | Decrease in frequency and absolute number of MAIT cells in peripheral blood of patients | [95] | |
P. aeruginosa infection with cystic fibrosis | Decrease in frequency of MAIT cells in peripheral blood of cystic fibrosis patients with P. aeruginosa infection | [96] | |
Cholera (Vibrio cholera O1) | Activation of MAIT cells in the acute phase No change of blood MAIT cell frequency in adult patients, but persistently decreased in child patients | [97] | |
Autoimmune diseases | Multiple sclerosis | Accumulation of MAIT cells in the central nervous system lesions Decrease in frequency of MAIT cells in peripheral blood | [44-46,48] |
Increased CD161high CD8+ T cells in peripheral blood | [98] | ||
Chronic inflammatory demyelinating polyneuropathy | Accumulation of MAIT cells in the peripheral nerves | [44] | |
Psoriatic and rheumatoid arthritis Rheumatoid arthritis | Enrichment of CD161high CD8+ T cells in the joints and secretion of IL-17 from those cells | [99] | |
Inflammatory bowel disease | Decrease in frequency and absolute number of MAIT cells (in particularly, in CD8+ and DN subsets) in peripheral blood | [53] | |
Increased MAIT cell levels in the synovial fluid Decrease in CD8+ MAIT cells in peripheral blood of CD and UC patients Accumulation of MAIT cells in the inflamed ileon of patients with CD Reduced IFN-γ production in CD patients and increased IL-17 production in CD and UC patients | [49] | ||
Fewer MAIT cells in in the inflamed ileon of patients with CD and UC Increased apoptosis in MAIT cells | [100] | ||
Psoriasis | MAIT cells reside in not only the dermis of patients but also that of health donors. MAIT cells may contribute IL-17 production in the dermis of patients | [51] | |
Celiac disease | Decrease in frequency of MAIT cells in peripheral blood and guts of adult and pediatric patients | [52] | |
Systemic lupus erythematosus | Decrease in frequency and absolute number of MAIT cells (in particularly, in CD8+ and DN subsets) in peripheral blood Reduced IFN-γ production Elevated expression of PD-1 in MAIT cells | [53] | |
Inflammatory diseases | Asthma | Decrease in frequency of MAIT cells in blood, sputum, and endobronchial biopsy | [101] |
Diabetes type 2/obesity | Decrease in frequency of MAIT cells in peripheral blood Circulating MAIT cells display an activate phenotype MAIT cells are more abundant in adipose tissue | [55,56] | |
Acute cholecystitis | Decrease in frequency and absolute number of MAIT cells in peripheral blood | [102] | |
Fibromyalgia syndrome vs Spondyloarthritis vs Rheumatoid arthritis | Defined analysis of MAIT cell phenotype among three diseases that exhibit a similar clinical manifestation Decrease in frequency of MAIT cells in three diseases Three diseases are able to distinguish by surface marker expression | [57] | |
Tissue transplant | Cutaneous acute graft-vs-host disease | Infiltration of CD8+ T cells, CD161+, CCR6+, RORγt+ in the epidermis and dermis of patients with GVHD | [103] |
Hemodialyzed and kidney transplant | Decrease in frequency of MAIT cells in peripheral blood Implication for the susceptibility to infections in the patients | [104] | |
Tumors | Kidney and brain tumors | Presence of MAIT cells in tumors | [58] |
Physiological change | Fetus | Rare and immature in the thymus, spleen, mesenteric lymph nodes Mature and enriched in the guts, liver, and lung | [29] |
Neonate/infant | Naïve phenotype at birth. Acquisition of effector/memory phenotype and increase in frequency and number with age | [11,30] | |
Adult | Maximum levels in the third and fourth decenniums Higher amounts in females with reproductive age than in males | [30] | |
Aging | Decrease in CD8+ MAIT cells and increase in CD4+ MAIT cells with age Th2 shift in cytokine profile in elderly | [22,30] |
Genotype | Characteristics | Ref. | |
Knockout mice | MR1-/- | Impaired development of MAIT cells | [79] |
Transgenic mice | Vα19 iTCR Tg | Enriched MAIT cells | [17,78-80] |
Vβ6 Vβ8 Tg | Increase of MAIT cells | [17] |
Category | Mouse strains | Disease model | Phenotype | Ref. |
Bacterial infection | MR1-/- Vα19 iTCR Tg Vβ6 Vβ8 Tg | Escherichia coliMicobacterium abcessus | Increase in the bacterial burden Repression of the bacterial burden | [16] |
MR1-/- | Klebsiella pneumoniae | Increased susceptibility to K. pneumoniae infection | [36] | |
MR1-/- | Mycobacterium bovis BCG | Enhanced bacterial growth at the early stage of infection | [35] | |
Francisella tularensis | Delayed adaptive immune reaction | [34] | ||
Autoimmune diseases | Vα19 iTCR Tg | Experimental autoimmune encephalomyelitis (model of MS) | Suppressed disease induction and progression | [78] |
MR1-/- | Collagen-induced arthritis (model of rheumatoid arthritis) | Improved CIA score | [86] | |
Adoptive transfer Jα33+ MAIT cells into BALB/c | TNBS induced colitis | Improved disease index | [105] | |
B10.RIII | Spondyloarthropathy by IL-23 | Enthesitis induced by IL-22 produced from IL-23R+RORγt+CD4-CD8- T cells (MAIT cells?) in the entheses | [91] | |
Others | Vα19 iTCR Tg NOD | Non-obese diabetes | Delayed disease onset | [106] |
Vα19 iTCR Tg | Delayed-type hypersensitivity to sheep erythrocytes (type IV allergy) | Suppression of the disease | [106] |
- Citation: Sugimoto C, Fujita H, Wakao H. Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases. World J Stem Cells 2016; 8(4): 158-169
- URL: https://www.wjgnet.com/1948-0210/full/v8/i4/158.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v8.i4.158